Brain Stimulation and Attention Control in Children With ADHD
Key facts
- Who runs it
- Neurolab Plus
- Where
- Kazakhstan2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 40 people, planned
- Started
- 4 Sept 2025
- Planned end
- Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Intermittent Theta Burst Stimulation to Right DLPFC
- Sham Intermittent Theta Burst Stimulation
- Record updated
- 19 September 2025
Who can take part
- Age
- 6 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Children aged 6-12 years at the time of enrollment
- Clinical diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD), any presentation type, confirmed using the Vanderbilt ADHD Diagnostic Parent Rating Scale and clinical interview
- Intelligence quotient (IQ) ≥ 70 as measured by the General Ability Index (GAI) from the Wechsler Intelligence Scale for Children - Fifth Edition (WISC-V)
- Ability to understand and follow instructions for the Attention Network Test (ANT) and stimulation procedure
- Stable medication regimen for ADHD (if any) for at least 4 weeks before the start of the study
- Written informed consent from a parent or legal guardian, and assent from the child when appropriate
Who cannot take part
- Presence of metal implants, devices, or foreign bodies in or near the head (except dental fillings) that are contraindicated for TMS or MRI
- History of epilepsy, seizures, or abnormal EEG suggestive of seizure risk
- Serious neurological disorders other than ADHD (e.g., cerebral palsy, brain injury, neurodegenerative disease)
- Severe psychiatric disorders requiring hospitalization or urgent intervention
- Current or past history of significant head trauma with loss of consciousness > 5 minutes
- Uncorrected hearing or vision problems that could interfere with task performance
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if brain stimulation can help children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) improve their attention and self-control. The main questions it aims to answer are:
Read full original descriptionShow less
Does intermittent theta burst stimulation (iTBS) improve performance on a task that tests attention and reaction times? Can brain activity and genetics help predict who benefits most from this treatment?
Researchers will compare randomly assigned active iTBS to sham (inactive) stimulation groups to see if the treatment helps.
Participants will:
Receive 10 sessions of either active or sham iTBS over 2 weeks Complete a computer task measuring attention before and after stimulation Wear a brain cap during the task to record EEG signals, also take part in resting-state brain scans, namely magnetic resonance imaging (MRI) and functional near-infrared spectroscopy (fNIRS), and provide a saliva sample for genetic testing
The 2 groups in the trial
- Active iTBS to Right DLPFCTreatment being tested
Participants receive active intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (DLPFC). Each session includes 600 pulses delivered in 2-second trains of 50 Hz bursts (triplets at 5 Hz), repeated every 10 seconds for a total duration of approximately 3 minutes, at 80% of active motor threshold. A total of 10 sessions is administered across two weeks.
Treatment: Intermittent Theta Burst Stimulation to Right DLPFC
- Sham iTBS (Right DLPFC)Sham treatment, for comparison
Participants receive sham stimulation over the right DLPFC using the same coil orientation, session structure, and auditory cues as the active iTBS group, but without magnetic field induction. Ten sham sessions are delivered over two weeks to maintain blinding and control for placebo effects.
Treatment: Sham Intermittent Theta Burst Stimulation
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of iTBS on Cognitive Control in Children With ADHD: A Randomized, Sham-Controlled Study Integrating EEG During ANT, fNIRS, MRI, and Genetic Markers
- Criteria questions
- Built from NCT07182344, who can take part
- Record updated
- 19 September 2025